Healthcare predictions we got right for 2022: As we expected, the lines between healthcare and retail blurred, and consumers cozied up with connected health devices. We detail other predictions we got right for the year.
Disruption in the digital pharmacy space: We unpack developments with Medly, NowRx, and Mark Cuban Cost Plus Drugs and look ahead to what’s in store for 2023.
Assessing if digital therapies are evaluated fairly: A new report pushes for digital therapeutics to have their own standard of evidence. Do the authors have a valid argument?
Solving unmet food needs improves patients’ health: We predict food as medicine programs that demonstrate healthcare cost savings will generate more interest from providers and payers.
Easy access and short wait times drive consumers to telehealth: But virtual care providers will need to stay on top of their game to keep patients from going elsewhere.
Alexa, say it ain’t so: Amazon abruptly shuts down HIPAA-compliant third-party apps, but we think it could turn its voice assistant into a physician’s assistant.
Digital health startups to watch: This week, we spotlight tech-based managed services organization UpStream Healthcare and clinical trial services company Vial on the back of recent funding hauls.
Biotech firms suffer job cuts: Being in one of the biggest growth sectors in technology has not insulated the biotech sector during tech’s cold winter, but there are signs that it could be one of the first sectors to bounce back.
Thirty Madison goes into sleep mode: The D2C digital health company is quietly building a new vertical focused on sleep health—but the customer acquisition costs will be high
CVS and Walgreens reshape the role of pharmacists: We unpack recent moves both have made to address labor shortages, burnout, and other realities.
Separating the winners and losers among digital health startups: VC investors have a grim outlook on startup valuations—here's how their business strategies might shift to secure funding in 2023.
Weak medical device security leads to patient harm: New survey data reveals just how laggard health systems are with protecting their medical devices. What will it take to improve?
AI tool can predict diabetes in 12 hours: We look at Klick Applied Sciences’ diagnostic tool that can screen for prediabetes in hours rather than days.
Good Measures launches prescription food delivery powered by Instacart: We unpack how health systems, health plans, and grocers are getting behind the food as medicine trend.
Convenience > loyalty drives where consumers get care: Our new forecast highlights where patients are getting care now and in the future, and which trends are driving that shift.
Kraydel launches a TV-based wellbeing platform: The Ireland-based digital health company is engaging older UK adults via a technology they know well.
Digital health startups to watch: This week, we spotlight healthcare fintech PayZen and health data monitoring company Medical Informatics Corp.
Google Health inks licensing deals for AI models: We unpack Google Health’s efforts to commercialize its AI solutions and examine if the company can secure clinician buy-in.
State AGs push for prolonged virtual opioid use disorder treatment: Telehealth increased the number of patients receiving addiction medications during the pandemic. Will patients lose this access in 2023?
Telemental health consolidation is coming: Amwell makes a second bid for Talkspace. We think it foreshadows a bigger trend for struggling telemental companies in 2023.